AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28587658 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of MRI structural lesions in patients with SIJ BME
Number of subjects: 185
Study 28587658 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean spinal scores in patients with SIJ structural lesions
Number of subjects: 185
Study 25754959 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% Intralipid infusion
Number of subjects: 9
Study 25754959 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 9
Study 23743969 — intervention group
Group type: EXPERIMENTAL
Intervention: Guayakí Yerba Maté Organic Energy Shot™ (YM; 140 mg caffeine)
Number of subjects: 6
Study 23743969 — intervention group
Group type: EXPERIMENTAL
Intervention: Red Bull Energy Shot™ (RB; 80 mg caffeine)
Number of subjects: 6
Study 23743969 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA; 0 mg caffeine)
Number of subjects: 6
Study 21271211 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (142 persons)
Number of subjects: 198
Study 21271211 — intervention group
Group type: COMPARATOR
Intervention: Control group (56 persons)
Number of subjects: 198
Study 19506919 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Disc Replacement (TDR)
Number of subjects: 152
Study 19506919 — intervention group
Group type: COMPARATOR
Intervention: Lumbar Fusion
Number of subjects: 152
Study 16681476 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-mg tadalafil
Number of subjects: 140
Study 16681476 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-mg tadalafil (in subgroup of patients taking it >=3 times per week)
Number of subjects: 140
Study 16681476 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 16302646 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral 17beta oestradiol (1 mg) and norethisterone (0.5 mg)
Number of subjects: 28
Study 16302646 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 11305707 — intervention group
Group type: EXPERIMENTAL
Intervention: Divalproex sodium
Number of subjects: 16
Study 11305707 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 9430805 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression of all compartments (calves, thighs, low abdomen, calves and thighs, and all compartments combined) using a modified antigravity suit
Number of subjects: 14
Study 9430805 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression of abdomen
Number of subjects: 14
Study 9430805 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression of all compartments
Number of subjects: 14
Study 9430805 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression of legs alone
Number of subjects: 14
Study 8297644 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 357
Study 8297644 — intervention group
Group type: COMPARATOR
Intervention: Surgery only (no radiotherapy)
Number of subjects: 357
Study 3430498 — intervention group
Group type: EXPERIMENTAL
Intervention: In-hospital management and nitrofurantoin suppression
Number of subjects: 100
Study 3430498 — intervention group
Group type: COMPARATOR
Intervention: Nitrofurantoin suppression
Number of subjects: 100
Study 29660937 — intervention group
Group type: EXPERIMENTAL
Intervention: Art intervention (singing and painting groups) for 12 weeks
Number of subjects: 50
Study 27743617 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular Aneurysm Repair (EVAR)
Number of subjects: 1252
Study 27743617 — intervention group
Group type: COMPARATOR
Intervention: Open Repair
Number of subjects: 1252
Study 24685997 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents as Teachers Enhanced (experimental arm)
Number of subjects: 150
Study 24685997 — intervention group
Group type: COMPARATOR
Intervention: Parents as Teachers (control arm)
Number of subjects: 150
Study 24685997 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 150
Study 21760491 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational support program (individual education, telephone health-coaching, small-group meetings)
Number of subjects: 48
Study 21760491 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational support program
Number of subjects: 48
Study 21760491 — intervention group
Group type: COMPARATOR
Intervention: Control group (no psychoeducational support)
Number of subjects: 48
Study 20156156 — intervention group
Group type: EXPERIMENTAL
Intervention: Second- and third-line antituberculosis agents
Number of subjects: 0
Study 18715216 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramlintide (30/60 microg administered subcutaneously at each meal)
Number of subjects: 248
Study 18715216 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 248
Study 16180526 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychodynamic short-term psychotherapy (PSTP), 25 therapy sessions
Number of subjects: 26
Study 16180526 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control condition
Number of subjects: 26
Study 16180526 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychodynamic short-term psychotherapy (PSTP)
Number of subjects: 26
Study 16180526 — intervention group
Group type: EXPERIMENTAL
Intervention: Child Behavior Checklist (CBCL)
Number of subjects: 26
Study 12558711 — intervention group
Group type: EXPERIMENTAL
Intervention: Low‐intensity, functionally oriented exercise and incontinence care provided every 2 hours from 8:00 a.m. to 4:00 p.m. for 5 days a week for 8 months
Number of subjects: 190
Study 12558711 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 190
Study 12558711 — intervention group
Group type: EXPERIMENTAL
Intervention: Low‐intensity, functionally oriented exercise and incontinence care
Number of subjects: 190
Study 10867984 — intervention group
Group type: EXPERIMENTAL
Intervention: mecamylamine (20 mg PO)
Number of subjects: 6
Study 10867984 — intervention group
Group type: EXPERIMENTAL
Intervention: mecamylamine (20 mg PO) and donepezil (5 mg PO)
Number of subjects: 6
Study 10867984 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 6
Study 8661208 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral liquid diet containing arginine and glutamine
Number of subjects: 14
Study 8661208 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral diet supplemented with pharmacologic amounts of glutamine and arginine
Number of subjects: 14
Study 8661208 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard enteral liquid diet
Number of subjects: 14
Study 8661208 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 14
Study 1829029 — intervention group
Group type: EXPERIMENTAL
Intervention: EE-DG (Ethinylestradiol 30 micrograms + Desogestrel 150 micrograms)
Number of subjects: 40
Study 1829029 — intervention group
Group type: EXPERIMENTAL
Intervention: EE-GD (Ethinylestradiol 30 micrograms + Gestodene 75 micrograms)
Number of subjects: 40
Study 6866592 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate HCl (Ritalin) administered intravenously or orally with breakfast
Number of subjects: 7
Study 6866592 — intervention group
Group type: COMPARATOR
Intervention: Methylphenidate HCl (Ritalin) administered intravenously or orally in a fasted state
Number of subjects: 7
Study 31965899 — intervention group
Group type: EXPERIMENTAL
Intervention: High viscosity cement (group A, n = 27 patients) with 2.8 mm cannula
Number of subjects: 52
Study 31965899 — intervention group
Group type: COMPARATOR
Intervention: Low viscosity cement (group B, n = 25 patients) with 4.2 mm cannula
Number of subjects: 52
Study 31965899 — intervention group
Group type: EXPERIMENTAL
Intervention: High viscosity cement (group A)
Number of subjects: 52
Study 31965899 — intervention group
Group type: COMPARATOR
Intervention: Low viscosity cement (group B)
Number of subjects: 52
Study 30649213 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy low-carbohydrate (HLC) diet
Number of subjects: 609
Study 30649213 — intervention group
Group type: COMPARATOR
Intervention: Healthy low-fat (HLF) diet
Number of subjects: 609
Study 29121989 — intervention group
Group type: EXPERIMENTAL
Intervention: PT-led primary care model for back pain
Number of subjects: 0
Study 29121989 — intervention group
Group type: COMPARATOR
Intervention: Usual physician‐led primary care model
Number of subjects: 0
Study 25963022 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental vitamins K and D and calcium
Number of subjects: 0
Study 22749707 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine with epinephrine 1:100,000
Number of subjects: 42
Study 22749707 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine with epinephrine 1:200,000
Number of subjects: 42
Study 22749707 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 42
Study 22420108 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-rating of personality traits
Number of subjects: 154
Study 22420108 — intervention group
Group type: COMPARATOR
Intervention: Average peer rating of personality traits
Number of subjects: 154
Study 19566950 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient education program including in-office physician counseling and patient mailings
Number of subjects: 0
Study 17718018 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-fortified salt (DFS)
Number of subjects: 0
Study 17718018 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodized salt
Number of subjects: 0
Study 17718018 — intervention group
Group type: COMPARATOR
Intervention: Simulated household conditions
Number of subjects: 0
Study 15849207 — intervention group
Group type: EXPERIMENTAL
Intervention: Pethidine 20 mg (Group P)
Number of subjects: 90
Study 15849207 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 0.5 mg kg(‐1) (Group K)
Number of subjects: 90
Study 15849207 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Group S)
Number of subjects: 90
Study 12221161 — intervention group
Group type: EXPERIMENTAL
Intervention: STN stimulation with voltages >= 3 V and frequencies >= 130 Hz
Number of subjects: 12
Study 12221161 — intervention group
Group type: EXPERIMENTAL
Intervention: STN stimulation with a rate of 5 Hz
Number of subjects: 12
Study 12221161 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of highest voltage with narrowest pulse width
Number of subjects: 12
Study 10458252 — intervention group
Group type: EXPERIMENTAL
Intervention: CJ‐11,974 100 mg
Number of subjects: 61
Study 10458252 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 7798528 — intervention group
Group type: EXPERIMENTAL
Intervention: Etilefrine (10 mg three times a day)
Number of subjects: 30
Study 7798528 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 2086821 — intervention group
Group type: EXPERIMENTAL
Intervention: Aztreonam (AZT) alone
Number of subjects: 104
Study 2086821 — intervention group
Group type: EXPERIMENTAL
Intervention: Aztreonam (AZT) plus Cefmetazole (CMZ)
Number of subjects: 104
Study 2086821 — intervention group
Group type: EXPERIMENTAL
Intervention: Aztreonam (AZT) plus Piperacillin (PIPC)
Number of subjects: 104
Study 2086821 — intervention group
Group type: EXPERIMENTAL
Intervention: Aztreonam (AZT) plus Amikacin (AMK)
Number of subjects: 104
Study 2086821 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall efficacy
Number of subjects: 104
Study 2086821 — intervention group
Group type: EXPERIMENTAL
Intervention: Infections caused by Gram-negative bacilli
Number of subjects: 104
Study 2086821 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of AZT and CMZ or PIPC for Escherichia coli infections
Number of subjects: 104
Study 2086821 — intervention group
Group type: EXPERIMENTAL
Intervention: Efficacy rates by neutrophil counts
Number of subjects: 104
Study 2086821 — intervention group
Group type: EXPERIMENTAL
Intervention: Infections with unidentified causative organisms
Number of subjects: 104
Study 2086821 — intervention group
Group type: EXPERIMENTAL
Intervention: Infections with identified causative organisms
Number of subjects: 104
Study 2086821 — intervention group
Group type: EXPERIMENTAL
Intervention: Sepsis and suspected sepsis
Number of subjects: 104
Study 2086821 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumonia and respiratory tract infection
Number of subjects: 104
Study 2086821 — intervention group
Group type: EXPERIMENTAL
Intervention: Fever of undetermined origin
Number of subjects: 104
Study 2086821 — intervention group
Group type: EXPERIMENTAL
Intervention: Other infections
Number of subjects: 104
Study 349582 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 0
Study 349582 — intervention group
Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 0
Study 31842974 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic chest drainage system (Drentech™ Palm Evo)
Number of subjects: 382
Study 31842974 — intervention group
Group type: COMPARATOR
Intervention: Traditional chest drainage system (Drentech™ Compact)
Number of subjects: 382
Study 31842974 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital chest drainage system
Number of subjects: 382
Study 27808417 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam
Number of subjects: 7
Study 27808417 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 25884315 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate (CHO) supplementation (1.2 g.kg(‐1) body mass.h(‐1) in a 20% CHO solution)
Number of subjects: 11
Study 25884315 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (CAF) supplementation (6 mg.kg(‐1) body mass)
Number of subjects: 11
Study 25884315 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined CHO and CAF (CHO+CAF)
Number of subjects: 11
Study 25884315 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 23665888 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at the PC6 point
Number of subjects: 228
Study 23665888 — intervention group
Group type: COMPARATOR
Intervention: No preventive care (routine medical treatment)
Number of subjects: 228
Study 21819189 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment (coil placement)
Number of subjects: 2143
Study 21819189 — intervention group
Group type: COMPARATOR
Intervention: Neurosurgical treatment (clip occlusion)
Number of subjects: 2143
Study 19135345 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose parenteral vinpocetine (VP) at doses gradually increased to 1 mg/kg/day
Number of subjects: 40
Study 19135345 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vinpocetine (VP) 30 mg for 3 months
Number of subjects: 40
Study 19135345 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 40
Study 17955649 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-penetrating acupuncture
Number of subjects: 90
Study 17955649 — intervention group
Group type: COMPARATOR
Intervention: Body acupuncture
Number of subjects: 90
Study 17955649 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study 15472176 — intervention group
Group type: EXPERIMENTAL
Intervention: GH at 25.0 microg/kg x d (pediatric dose)
Number of subjects: 149
Study 15472176 — intervention group
Group type: EXPERIMENTAL
Intervention: GH at 12.5 microg/kg x d (adult dose)
Number of subjects: 149
Study 15472176 — intervention group
Group type: COMPARATOR
Intervention: GH treatment (both doses)
Number of subjects: 149
Study 15472176 — intervention group
Group type: COMPARATOR
Intervention: Control (no GH treatment)
Number of subjects: 149
Study 11549829 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole (30 mg twice daily), Amoxycillin (1000 mg twice daily), Clarithromycin (500 mg twice daily) for 14 days (LAC)
Number of subjects: 48
Study 11549829 — intervention group
Group type: COMPARATOR
Intervention: Lansoprazole (30 mg four times daily), Bismuth subsalicylate (2 tablets four times daily), Metronidazole (250 mg four times daily), Tetracycline (250 mg four times daily) for 14 days (LBMT)
Number of subjects: 48
Study 9610529 — intervention group
Group type: EXPERIMENTAL
Intervention: High baseline levels of C-reactive protein (CRP)
Number of subjects: 14916
Study 9610529 — intervention group
Group type: EXPERIMENTAL
Intervention: Total cholesterol (TC)
Number of subjects: 14916
Study 9610529 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP)
Number of subjects: 14916
Study 9610529 — intervention group
Group type: EXPERIMENTAL
Intervention: Models incorporating CRP and lipid parameters
Number of subjects: 14916
Study 9610529 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline CRP level
Number of subjects: 14916
Study 9610529 — intervention group
Group type: EXPERIMENTAL
Intervention: Analyses limited to nonsmokers and after control for other cardiovascular risk factors
Number of subjects: 14916
Study 8111257 — intervention group
Group type: EXPERIMENTAL
Intervention: Low total fat diet (8% saturated fat, approximately 200 mg/day cholesterol)
Number of subjects: 63
Study 8111257 — intervention group
Group type: EXPERIMENTAL
Intervention: High unsaturated fat diet (8% saturated fat, approximately 200 mg/day cholesterol)
Number of subjects: 63
Study 8111257 — intervention group
Group type: COMPARATOR
Intervention: Normal control diet
Number of subjects: 63
Study 2972548 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine 10 mg
Number of subjects: 0
Study 2972548 — intervention group
Group type: EXPERIMENTAL
Intervention: Terfenadine 60 mg
Number of subjects: 0
Study 2972548 — intervention group
Group type: EXPERIMENTAL
Intervention: Clemastine 1 mg
Number of subjects: 0
Study 2972548 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2972548 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 5 mg
Number of subjects: 0
Study 49649 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin
Number of subjects: 4121
Study 49649 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 4121
Study 30969846 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvage autologous stem-cell transplantation (sASCT)
Number of subjects: 288
Study 30969846 — intervention group
Group type: COMPARATOR
Intervention: Nontransplantation consolidation (NTC)
Number of subjects: 288
Study 26181504 — intervention group
Group type: EXPERIMENTAL
Intervention: Viscous lidocaine
Number of subjects: 100
Study 26181504 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 26181504 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups pooled
Number of subjects: 100
Study 26521106 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine A (CYA) combined with low-dose corticosteroids (CS)
Number of subjects: 99
Study 26521106 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide (CPA) combined with low-dose corticosteroids (CS)
Number of subjects: 99
Study 26521106 — intervention group
Group type: EXPERIMENTAL
Intervention: CYA and CPA groups
Number of subjects: 99
Study 23599381 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevelamer (n=55)
Number of subjects: 120
Study 23599381 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=54)
Number of subjects: 120
Study 23599381 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevelamer (compliant subgroup)
Number of subjects: 120
Study 22080720 — intervention group
Group type: EXPERIMENTAL
Intervention: Small class size (13-17 students)
Number of subjects: 11601
Study 19420364 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stents
Number of subjects: 3006
Study 19420364 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents
Number of subjects: 3006
Study 16807142 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobramycin nebuliser solution (TNS)
Number of subjects: 21
Study 16807142 — intervention group
Group type: COMPARATOR
Intervention: Colistin (C)
Number of subjects: 21
Study 12651203 — intervention group
Group type: EXPERIMENTAL
Intervention: salvage HD-CT
Number of subjects: 58
Study 12651203 — intervention group
Group type: EXPERIMENTAL
Intervention: complete resection of residual masses
Number of subjects: 58
Study 12651203 — intervention group
Group type: EXPERIMENTAL
Intervention: favourable response to salvage therapy
Number of subjects: 58
Study 12651203 — intervention group
Group type: COMPARATOR
Intervention: no specific therapy
Number of subjects: 58
Study 11147613 — intervention group
Group type: EXPERIMENTAL
Intervention: Semiannual chest X-rays and sputum investigation (intervention group, 3171 participants)
Number of subjects: 6364
Study 11147613 — intervention group
Group type: COMPARATOR
Intervention: One examination only by chest X-rays and sputum investigation (control group, 3174 participants)
Number of subjects: 6364
Study 8935624 — intervention group
Group type: EXPERIMENTAL
Intervention: Infrared video camera system for measuring nocturnal scratching
Number of subjects: 10
Study 8935624 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-itchy healthy controls)
Number of subjects: 10
Study 1576095 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose nisoldipine (2 micrograms/kg) as a single intravenous injection over a 3-minute period
Number of subjects: 24
Study 1576095 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose nisoldipine (double the low dose)
Number of subjects: 24
Study 1576095 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 2579496 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal transurethral prostatic resection (TUR-P)
Number of subjects: 81
Study 2579496 — intervention group
Group type: EXPERIMENTAL
Intervention: Total transurethral prostatic resection (TUR-P)
Number of subjects: 81
Study 2579496 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 81
Study 30935335 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical spinal manipulation (CSM)
Number of subjects: 28
Study 30935335 — intervention group
Group type: COMPARATOR
Intervention: Sham CSM
Number of subjects: 28
Study 29235186 — intervention group
Group type: EXPERIMENTAL
Intervention: WebQuit.org (ACT for smoking cessation)
Number of subjects: 2637
Study 29235186 — intervention group
Group type: COMPARATOR
Intervention: Smokefree.gov (US Clinical Practice Guidelines for smoking cessation)
Number of subjects: 2637
Study 27244700 — intervention group
Group type: EXPERIMENTAL
Intervention: HYADD 4
Number of subjects: 75
Study 27244700 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid (CS)
Number of subjects: 75
Study 24576886 — intervention group
Group type: EXPERIMENTAL
Intervention: PACK-CXL treatment in addition to antimicrobial therapy
Number of subjects: 40